DSMFF (DSM-Firmenich AG) Dividends Received


DSMFF DSM-Firmenich AG DSMFF
53 GF Score
Price $88.19
GF Value $78.76
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is DSM-Firmenich AG Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

DSMFF
53GF Score
DSM-Firmenich AG DSMFF
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is DSM-Firmenich AG (DSMFF) Overvalued in 2026?

Based on GuruFocus' analysis, DSM-Firmenich AG stock appears to be overvalued. The current stock price of $88.19 is trading 12% above its estimated GF Value™ of $78.76. GuruFocus considers DSM-Firmenich AG to be Modestly Overvalued.

Key valuation signals for DSMFF:

  • Dividends Received:
  • GF Value™: $78.76 vs. price of $88.19 (12% above fair value)
  • GF Score™: 53/100 with 8 warning signs

No single metric tells the full story. See the DSMFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DSM-Firmenich AG Business Description

Address Wurmisweg 576, Kaiseraugst, CHE, 4303
DSM-Firmenich is a global science-based company formed in 2023 through the merger of DSM, a Dutch nutrition, health, and sustainable living player, and Switzerland-based Firmenich, the third-largest player in the flavor and fragrance market. The company serves a wide range of end-consumer markets providing nutrition solutions ranging from medical and early-life nutrition, fragrances for personal-, home-, and laundry-care brands, prestige perfumes, and other ingredients for food and beverage, home, and personal care. DSM-Firmenich has nearly 30,000 employees, with more than 2,000 scientists and engineers spread across 15 research and development facilities.
53GF Score

Get the complete analysis for DSMFF

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$88.19
Price
$78.76
GF Value